Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,266 | -210,752 | -153,754 | -102,052 | -49,500 |
| Depreciation Amortization | 124 | 712 | 592 | 513 | 331 |
| Accounts payable and accrued liabilities | 1,945 | 2,688 | 8,133 | 2,559 | -431 |
| Other Working Capital | -517 | 8,180 | 10,921 | 8,941 | 1,798 |
| Other Operating Activity | 6,885 | 30,044 | 16,530 | 13,722 | 8,038 |
| Operating Cash Flow | $-45,829 | $-169,128 | $-117,578 | $-76,317 | $-39,764 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,372 | -9,420 | -8,300 | -6,243 | -2,383 |
| Purchase Of Investment | -85,564 | -261,293 | -192,285 | -133,208 | -64,274 |
| Sale Of Investment | 67,408 | 174,703 | 124,898 | 88,618 | 50,802 |
| Investing Cash Flow | $-19,528 | $-96,010 | $-75,687 | $-50,833 | $-15,855 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 40,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -3,856 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 288,435 | 190,435 | 195,820 | 189,463 |
| Other Financing Activity | 2,760 | 10,727 | 7,763 | 0 | 1,993 |
| Financing Cash Flow | $38,904 | $299,162 | $198,198 | $195,820 | $191,456 |
| Beginning Cash Position | 107,511 | 73,487 | 73,487 | 73,487 | 73,487 |
| End Cash Position | 81,058 | 107,511 | 78,420 | 142,157 | 209,324 |
| Net Cash Flow | $-26,453 | $34,024 | $4,933 | $68,670 | $135,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,829 | -169,128 | -117,578 | -76,317 | -39,764 |
| Capital Expenditure | -1,372 | -9,420 | -8,300 | -6,243 | -2,383 |
| Free Cash Flow | -47,201 | -178,548 | -125,878 | -82,560 | -42,147 |